[go: up one dir, main page]

MXPA03010529A - Derivados de imidazol [1,5a]pirimido[5,4-d]benzazepina, como moduladores del receptor gaba a. - Google Patents

Derivados de imidazol [1,5a]pirimido[5,4-d]benzazepina, como moduladores del receptor gaba a.

Info

Publication number
MXPA03010529A
MXPA03010529A MXPA03010529A MXPA03010529A MXPA03010529A MX PA03010529 A MXPA03010529 A MX PA03010529A MX PA03010529 A MXPA03010529 A MX PA03010529A MX PA03010529 A MXPA03010529 A MX PA03010529A MX PA03010529 A MXPA03010529 A MX PA03010529A
Authority
MX
Mexico
Prior art keywords
lower alkyl
gaba
pyrimido
imidazo
receptor modulators
Prior art date
Application number
MXPA03010529A
Other languages
English (en)
Inventor
Masciadri Raffaello
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MXPA03010529A publication Critical patent/MXPA03010529A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La presente invencion se refiere a compuestos de formula (ver formula). en donde R1 es halogeno o alquilo inferior; R2 es hidrogeno, alquilo inferior, cicloalquilo, - (CH2)m fenilo, en donde el anillo fenilo puede estar sustituido con alcoxilo-inferior, o es - (CH2) ,-indolilo; R3 es -C(O)O-alquilo inferior, -C(O)OH, o un grupo heteroaromatico de cinco miembros, cuyos anillos pueden estar sustituidos con alquilo inferior o cicloalquilo; n es 0, 1 o 2; m es 0, 1 o 2; y sus sales de adicion acida farmaceuticamente aceptables. Se ha descubierto que esta clase de compuestos muestran una elevada afinidad y selectividad para los sitios de union del receptor (5 de GABA A y pueden ser utiles para el tratamiento de mejoras cognitivas o de trastornos cognitivos como la enfermedad de Alzheimer.
MXPA03010529A 2001-05-18 2002-05-08 Derivados de imidazol [1,5a]pirimido[5,4-d]benzazepina, como moduladores del receptor gaba a. MXPA03010529A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01112222 2001-05-18
PCT/EP2002/005121 WO2002094834A1 (en) 2001-05-18 2002-05-08 Imidazo [1,5-a] pyrimido [5,4-d] benzazepine derivatives as gaba a receptor modulators

Publications (1)

Publication Number Publication Date
MXPA03010529A true MXPA03010529A (es) 2004-03-02

Family

ID=8177471

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03010529A MXPA03010529A (es) 2001-05-18 2002-05-08 Derivados de imidazol [1,5a]pirimido[5,4-d]benzazepina, como moduladores del receptor gaba a.

Country Status (37)

Country Link
US (1) US6686352B2 (es)
EP (1) EP1399448B1 (es)
JP (1) JP4068466B2 (es)
KR (1) KR100533406B1 (es)
CN (1) CN1230436C (es)
AR (1) AR033753A1 (es)
AT (1) ATE283857T1 (es)
AU (1) AU2002338898B2 (es)
BG (1) BG108369A (es)
BR (1) BR0209859A (es)
CA (1) CA2446903C (es)
CZ (1) CZ20033355A3 (es)
DE (1) DE60202147T2 (es)
DK (1) DK1399448T3 (es)
EC (1) ECSP034851A (es)
ES (1) ES2232778T3 (es)
GT (1) GT200200087A (es)
HR (1) HRP20030890A2 (es)
HU (1) HUP0400743A3 (es)
IL (2) IL158572A0 (es)
JO (1) JO2297B1 (es)
MA (1) MA27024A1 (es)
MX (1) MXPA03010529A (es)
MY (1) MY127570A (es)
NO (1) NO20035104D0 (es)
NZ (1) NZ529097A (es)
PA (1) PA8545201A1 (es)
PE (1) PE20030041A1 (es)
PL (1) PL366846A1 (es)
PT (1) PT1399448E (es)
RU (1) RU2287531C2 (es)
SI (1) SI1399448T1 (es)
SK (1) SK15252003A3 (es)
TW (1) TWI251489B (es)
WO (1) WO2002094834A1 (es)
YU (1) YU90003A (es)
ZA (1) ZA200308544B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4467616B2 (ja) 2004-05-14 2010-05-26 ミレニアム・ファーマシューティカルズ・インコーポレイテッド Auroraキナーゼの阻害により有糸分裂の進行を阻止するための化合物および方法
CA2582235A1 (en) * 2004-10-04 2006-04-20 Millennium Pharmaceuticals, Inc. Lactam compounds useful as protein kinase inhibitors
ES2399439T3 (es) * 2004-10-20 2013-04-01 F. Hoffmann-La Roche Ag Derivados de imidazo-benzodiazepina
RU2007114763A (ru) * 2004-10-20 2008-11-27 Ф.Хоффманн-Ля Рош Аг (Ch) Галогенозамещенные производные бензодиазепинов
EP1937688B1 (en) 2005-10-11 2010-08-11 F. Hoffmann-La Roche AG Imidazo benzodiazepine derivatives
PE20080145A1 (es) * 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
WO2009078999A1 (en) 2007-12-17 2009-06-25 Janssen Pharmaceutica N.V. Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1
CN101735211B (zh) * 2008-11-04 2012-11-14 复旦大学 2,3-二氢[1,5]苯并噻氮杂*类化合物或其盐在制备GSK-3β抑制剂中的用途
WO2010065134A1 (en) * 2008-12-05 2010-06-10 Millennium Pharmaceuticals, Inc. 5, 7-dihydro- 6h-pyrimido [ 5, 4-d] [ 1 ] benzazepin-6-thiones as plk inhibitors
BRPI0923579A2 (pt) 2008-12-22 2020-01-14 Millennium Pharm Inc combinação de inibidores de aurora quinase e anticorpos anti-cd20
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
WO2011103089A1 (en) 2010-02-19 2011-08-25 Millennium Pharmaceuticals, Inc. Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6--methoxyphenyl)-5h -pyrimido[5,4-d][2]benzazepin-2yl]amino}-2-methoxybenzoate
CN101891706B (zh) * 2010-04-09 2013-05-29 复旦大学 3,4-二氢苯并[f][1,4]噻氮杂*类化合物或其盐及其药物用途
CN102424670A (zh) * 2011-10-31 2012-04-25 江苏阿尔法药业有限公司 一种合成3-(3-氯丙基)-1,3,4,5-四氢-7,8-二甲氧基-2h-3-苯并氮杂卓-2-酮的方法
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
CA2907726A1 (en) 2013-03-22 2014-09-25 Millennium Pharmaceuticals, Inc. Combination of catalytic mtorc1/2 inhibitors and selective inhibitors of aurora a kinase
CA3123897C (en) 2013-12-20 2024-02-06 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CN108026107B (zh) 2015-06-19 2021-07-30 艾吉因生物股份有限公司 用于治疗认知损害的苯并二氮杂环庚三烯衍生物、组合物和方法
JP2018524292A (ja) 2015-07-21 2018-08-30 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. オーロラキナーゼインヒビターと化学療法剤の投与
BR112019012821A2 (pt) 2016-12-19 2019-11-26 Agenebio Inc derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo
WO2019246300A1 (en) 2018-06-19 2019-12-26 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CN110452172B (zh) * 2019-08-21 2021-03-26 爱斯特(成都)生物制药股份有限公司 一种苯并己内酰胺的合成方法
CN112159411A (zh) * 2020-10-15 2021-01-01 南京工业大学 一种三氟甲基取代嘧啶并[1,3]二氮杂*化合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2607503B1 (fr) * 1986-12-02 1989-02-24 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
TW201311B (es) 1991-06-17 1993-03-01 Hoffmann La Roche
RU2119496C1 (ru) * 1992-04-14 1998-09-27 Научно-исследовательский институт фармакологии Российской академии медицинских наук Производные n-ацилпролилдипептидов
FR2728902B1 (fr) * 1994-12-29 1997-01-31 Synthelabo Derives d'acide 8-oxo-5,8-dihydro-6h-dibenzo(a,g)quinolizine-13-propanoique, leur preparation et leur application en therapeutique
US6166203A (en) * 1998-02-26 2000-12-26 Neurogen Corporation Heterocyclic amino substituted heteroaryl fused pyridines; GABA brain receptor ligands
US6177569B1 (en) * 1998-08-25 2001-01-23 Neurogen Corporation Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
FR2783828B1 (fr) 1998-09-29 2000-11-10 Synthelabo Derives d'acide 5,6-dihydro-4h-imidazo[1,2-a][1] benzazepine -1-acetique, leur preparation et leur application en therapeutique
MXPA02004735A (es) 1999-11-12 2003-01-28 Orive Javier Uhthoff Compuestos heteroaromaticos, biciclicos y triciclicos.
TWI239333B (en) 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators

Also Published As

Publication number Publication date
BG108369A (bg) 2005-01-31
DE60202147T2 (de) 2005-12-01
MY127570A (en) 2006-12-29
EP1399448A1 (en) 2004-03-24
PT1399448E (pt) 2005-03-31
HK1066544A1 (en) 2005-03-24
WO2002094834A1 (en) 2002-11-28
NZ529097A (en) 2005-04-29
YU90003A (sh) 2006-08-17
RU2003136078A (ru) 2005-05-27
PL366846A1 (en) 2005-02-07
ZA200308544B (en) 2005-01-31
ES2232778T3 (es) 2005-06-01
TWI251489B (en) 2006-03-21
KR20040002975A (ko) 2004-01-07
NO20035104L (no) 2003-11-17
ATE283857T1 (de) 2004-12-15
CZ20033355A3 (en) 2004-07-14
PA8545201A1 (es) 2003-02-28
RU2287531C2 (ru) 2006-11-20
IL158572A0 (en) 2004-05-12
PE20030041A1 (es) 2003-02-07
NO20035104D0 (no) 2003-11-17
US6686352B2 (en) 2004-02-03
AU2002338898B8 (en) 2002-12-03
GT200200087A (es) 2003-06-19
ECSP034851A (es) 2003-12-24
IL158572A (en) 2010-02-17
AU2002338898B2 (en) 2007-03-15
JP4068466B2 (ja) 2008-03-26
JO2297B1 (en) 2005-09-12
CA2446903A1 (en) 2002-11-28
JP2004531563A (ja) 2004-10-14
DK1399448T3 (da) 2005-04-11
HUP0400743A3 (en) 2007-09-28
CA2446903C (en) 2008-12-30
SI1399448T1 (en) 2005-02-28
EP1399448B1 (en) 2004-12-01
CN1230436C (zh) 2005-12-07
DE60202147D1 (de) 2005-01-05
HRP20030890A2 (en) 2005-08-31
KR100533406B1 (ko) 2005-12-02
BR0209859A (pt) 2004-06-15
CN1509289A (zh) 2004-06-30
HUP0400743A2 (hu) 2004-07-28
AR033753A1 (es) 2004-01-07
US20030055042A1 (en) 2003-03-20
SK15252003A3 (sk) 2004-08-03
MA27024A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
MXPA03010529A (es) Derivados de imidazol [1,5a]pirimido[5,4-d]benzazepina, como moduladores del receptor gaba a.
CA2401229A1 (en) Aryl fused azapolycyclic compounds
GC0000375A (en) Benzodiazepine derivatives as gaba a receptor modulators
CA2520898A1 (en) Non-cross-linking pyrrolo(2,1-c)(1,4)benzodiazepines as potential antitumour agents and process thereof
BG107120A (bg) Нови бавнодействащи бетамиметици, метод за тяхното получаване и приложението им като лекарствени средства
WO2005113536A3 (en) Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
MX2007000044A (es) Compuestos, composiciones y metodos de tetrahidroquinazolin-4(3h)- ona-relacionados y tetrahidropirido [2,3-d] pirimidin-4(3h)-ona- relacionados para su uso.
CA2375670A1 (en) 5-phenyl-pyrimidine derivatives
IL190398A0 (en) Imidazo benzodiazepine derivatives
TW200630372A (en) Imidazo-benzodiazepine derivatives
TW200734328A (en) Aryl-isoxazolo-4-yl-imidazo [1,5-a] pyridine derivatives
DE602005008633D1 (de) Imidazoä1,5aütriazoloä1,5dübenzodiazepin-derivative zur behandlung kognitiver störungen
TW200631953A (en) Tetracyclic imidazo-benzodiazepines
WO2007054444A3 (en) 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
MX2007004640A (es) Derivados de benzodiazepina sustituidos con halogeno.
WO2003045940A3 (en) Benzazepine derivatives and their use as 5-ht ligands
TW200500365A (en) Preparation of substituted quinoxalines
WO2005007630A3 (en) Aryl fused azapolycyclic compounds
GB2425309A (en) C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers
SE0400440D0 (sv) Novel Cinnamic Amides
SE0100297D0 (sv) New compounds
MXPA06000774A (es) E3-nitro-pirazolo[1,5-a]pirimidinas 7-sustituidas y composiciones y metodos relacionados.
SE0100295D0 (sv) New compounds
TNSN05324A1 (en) 7-substituted 3-nitro-pyrazolo `1,5-a! pyrimidines
TNSN05325A1 (en) N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND COMPOSITIONS, AND METHODS RELATED THERETO

Legal Events

Date Code Title Description
FG Grant or registration